Skip to main content

Verrica Pharmaceuticals Inc.

VRCA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001660334

In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Verrica Pharmaceuticals Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
39
−10 vs. Q4 2025
Shares held
4.78M
−280.1K (−5.5%) vs. Q4 2025
Total value
$25.3M
−$16.7M (−39.8%) vs. Q4 2025
New holders
6
10 more added
Sold out
16
7 more reduced

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VRCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 39 institutions
Q1 2021: 51 institutionsQ2 2021: 53 institutionsQ3 2021: 49 institutionsQ4 2021: 45 institutionsQ1 2022: 51 institutionsQ2 2022: 57 institutionsQ3 2022: 49 institutionsQ4 2022: 50 institutionsQ1 2023: 60 institutionsQ2 2023: 63 institutionsQ3 2023: 67 institutionsQ4 2023: 64 institutionsQ1 2024: 62 institutionsQ2 2024: 74 institutionsQ3 2024: 79 institutionsQ4 2024: 81 institutionsQ1 2025: 75 institutionsQ2 2025: 59 institutionsQ3 2025: 34 institutionsQ4 2025: 50 institutionsQ1 2026: 39 institutionsQ2 2026: 43 institutions
Value heldQ1 2026: $25.3M
Q1 2021: $150.4MQ2 2021: $112.3MQ3 2021: $114.6MQ4 2021: $82.0MQ1 2022: $72.1MQ2 2022: $21.8MQ3 2022: $29.9MQ4 2022: $29.8MQ1 2023: $84.2MQ2 2023: $84.2MQ3 2023: $58.5MQ4 2023: $131.8MQ1 2024: $105.1MQ2 2024: $135.9MQ3 2024: $21.6MQ4 2024: $21.0MQ1 2025: $13.0MQ2 2025: $13.4MQ3 2025: $10.6MQ4 2025: $43.2MQ1 2026: $25.3MQ2 2026: $28.5M
Institutions holding VRCA and their total value by quarter
QuarterHoldersValue
Q2 202643$28.5M
Q1 202639$25.3M
Q4 202550$43.2M
Q3 202534$10.6M
Q2 202559$13.4M
Q1 202575$13.0M
Q4 202481$21.0M
Q3 202479$21.6M
Q2 202474$135.9M
Q1 202462$105.1M
Q4 202364$131.8M
Q3 202367$58.5M
Q2 202363$84.2M
Q1 202360$84.2M
Q4 202250$29.8M
Q3 202249$29.9M
Q2 202257$21.8M
Q1 202251$72.1M
Q4 202145$82.0M
Q3 202149$114.6M
Q2 202153$112.3M
Q1 202151$150.4M

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Verrica Pharmaceuticals Inc.; share changes are against Q4 2025.

Institutions holding VRCA in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Caligan Partners LP923,910$4.89M0.35%00.0%Unchanged
Affinity Asset Advisors, LLC707,338$3.74M0.22%00.0%Unchanged
Cannell Capital LLC685,123$3.62M2.35%+685,123New
Armistice Capital, LLC518,181$2.74M0.09%−600,744−53.7%Reduced
Velan Capital Investment Management LP471,559$2.49M1.56%00.0%Unchanged
Boothbay Fund Management, LLC280,734$1.49M0.03%00.0%Unchanged
Vanguard Capital Management LLC188,758$998.5K0.00%+188,758New
DAFNA Capital Management LLC153,712$813.1K0.18%−19,739−11.4%Reduced
Marshall Wace, LLP140,497$743.2K0.00%+55,324+65.0%Added
Geode Capital Management, LLC138,917$735.0K0.00%+71,258+105.3%Added
Stonepine Capital Management, LLC99,735$527.6K0.46%−253,934−71.8%Reduced
Squarepoint Ops LLC75,208$397.9K0.00%+41,938+126.1%Added
Vanguard Fiduciary Trust Co65,101$344.4K0.00%+65,101New
Two Sigma Investments, LP50,662$268.0K0.00%−67,556−57.1%Reduced
Jane Street Group, LLC49,211$260.3K0.00%−52,511−51.6%Reduced
BlackRock, Inc.38,553$203.9K0.00%+32,868+578.2%Added
Renaissance Technologies LLC32,360$171.2K0.00%+5,960+22.6%Added
Northern Trust Corp31,580$167.1K0.00%+11,556+57.7%Added
State Street Corp28,916$153.0K0.00%+5,435+23.1%Added
Mariner, LLC24,544$129.8K0.00%00.0%Unchanged
Morgan Stanley22,386$118.4K0.00%+377+1.7%Added
Legacy Trust17,234$91.2K0.02%00.0%Unchanged
Verdad Advisers, LP12,098$64.0K0.07%+12,098New
Beck Mack & Oliver LLC12,000$63.5K0.00%00.0%Unchanged
UBS Group AG4,270$22.6K0.00%+4,246+17,691.7%Added
Capital Analysts, LLC1,500$8.00K0.00%00.0%Unchanged
Royal Bank of Canada965$5.00K0.00%+549+132.0%Added
Vanguard Global Advisers, LLC862$4.56K0.00%+862New
Tower Research Capital LLC (TRC)856$4.53K0.00%−2,486−74.4%Reduced
Salomon & Ludwin, LLC290$1.59K0.00%00.0%Unchanged
New England Capital Financial Advisors LLC200$1.06K0.00%00.0%Unchanged
International Assets Investment Management, LLC175$9610.00%00.0%Unchanged
Fortitude Family Office, LLC127$6720.00%−481−79.1%Reduced
BNP Paribas Arbitrage, SA110$5820.00%00.0%Unchanged
The PNC Financial Services Group, Inc.102$5400.00%00.0%Unchanged
JPMorgan Chase & Co47$2240.00%00.0%Unchanged
Optiver Holding B.V.31$1640.00%00.0%Unchanged
Jones Financial Companies LLLP26$1140.00%+26New
MAI Capital Management2$110.00%00.0%Unchanged
Kalehua Capital Management LLC0$00.00%−235,779−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−44,430−100.0%Sold out
Sovran Advisors, LLC0$00.00%−32,658−100.0%Sold out
Millennium Management LLC0$00.00%−23,123−100.0%Sold out
Omers Administration Corp0$00.00%−22,600−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−18,621−100.0%Sold out
HRT Financial LP0$00.00%−17,356−100.0%Sold out
Walleye Capital LLC0$00.00%−15,240−100.0%Sold out
XTX Topco Ltd0$00.00%−14,662−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−12,000−100.0%Sold out
Quadrature Capital Ltd0$00.00%−11,954−100.0%Sold out
Man Group plc0$00.00%−11,287−100.0%Sold out
Bank of America Corp0$00.00%−4,343−100.0%Sold out
Group One Trading, L.P.0$00.00%−3−100.0%Sold out
Barclays PLC0$00.00%−1−100.0%Sold out
Covestor Ltd0$00.00%−54−100.0%Sold out
Vanguard Group Inc––––Not filed